Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1975 Nov;55(3):359–368. doi: 10.1111/j.1476-5381.1975.tb06939.x

Antiarrhythmic, haemodynamic and metabolic effects of 3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride in greyhounds following acute coronary artery ligation.

R J Marshall, J R Parratt
PMCID: PMC1666686  PMID: 1133

Abstract

1 The antiarrhythmic, haemodynamic and metabolic effects of a new amino steroid, ORG6001, have been investigated in experimental acute myocardial infarction in anaesthetized greyhounds. 2 ORG6001 administered either intravenously (2-10 mg/kg) or orally (50 mg/kg) significantly reduced the incidence of ventricular ectopic beats in the first 30 min after ligation of the left anterior descending coronary artery. 3 In dogs pretreated with ORG6001, metabolic changes indicative of myocardial ischaemia (lactate production and potassium efflux) were less marked than those occurring in control animals. 4 Antiarrhythmic doses of ORG6001 caused only minimal transient haemodynamic effects. 5 These results suggest that ORG6001 may possess distinct advantages over presently-used antiarrhythmic drugs in the prevention and treatment of the early arrhythmias which occur after myocardial infarction.

Full text

PDF
359

Images in this article

361Figure 1
on p.361

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adgey A. A., Allen J. D., Geddes J. S., James R. G., Webb S. W., Zaidi S. A., Pantridge J. F. Acute phase of myocardial infarction. Lancet. 1971 Sep 4;2(7723):501–504. doi: 10.1016/s0140-6736(71)90434-x. [DOI] [PubMed] [Google Scholar]
  2. Austen W. G., Moran J. M. Cardiac and peripheral vascular effects of lidocaine and procainamide. Am J Cardiol. 1965 Nov;16(5):701–707. doi: 10.1016/0002-9149(65)90054-8. [DOI] [PubMed] [Google Scholar]
  3. Gordon T., Kannel W. B. Premature mortality from coronary heart disease. The Framingham study. JAMA. 1971 Mar 8;215(10):1617–1625. [PubMed] [Google Scholar]
  4. Gorlin R. Assessment of hypoxia in the human heart. Cardiology. 1972;57(1):24–34. doi: 10.1159/000169501. [DOI] [PubMed] [Google Scholar]
  5. HARRIS A. S., BISTENI A., RUSSELL R. A., BRIGHAM J. C., FIRESTONE J. E. Excitatory factors in ventricular tachycardia resulting from myocardial ischemia; potassium a major excitant. Science. 1954 Feb 12;119(3085):200–203. doi: 10.1126/science.119.3085.200. [DOI] [PubMed] [Google Scholar]
  6. Ledingham I. M., McBride T. I., Parratt J. R., Vance J. P. The effect of hypercapnia on myocardial blood flow and metabolism. J Physiol. 1970 Sep;210(1):87–105. doi: 10.1113/jphysiol.1970.sp009197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ledingham I. M., Parratt J. R., Smith G., Vance J. P. Haemodynamic and myocardial effects of hyperbaric oxygen in dogs subjected to haemorrhage. Cardiovasc Res. 1971 Jul;5(3):277–285. doi: 10.1093/cvr/5.3.277. [DOI] [PubMed] [Google Scholar]
  8. Marhsall R. J., Parratt J. R. The effect of noradrenaline on blood flow and oxygen consumption in normal and ischemic areas of myocardium. Am Heart J. 1973 Nov;86(5):653–662. doi: 10.1016/0002-8703(73)90343-8. [DOI] [PubMed] [Google Scholar]
  9. Marshall R. J., Parratt J. R., Ledingham I. M. Changes in blood flow and oxygen consumption in normal and ischaemic regions of the myocardium following acute coronary artery ligation. Cardiovasc Res. 1974 Mar;8(2):204–215. doi: 10.1093/cvr/8.2.204. [DOI] [PubMed] [Google Scholar]
  10. Mason D. T., DeMaria A. N., Amsterdam E. A., Zelis R., Massumi R. A. Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology. Drugs. 1973;5(4):261–291. doi: 10.2165/00003495-197305040-00002. [DOI] [PubMed] [Google Scholar]
  11. Opie L. H., Owen P., Thomas M., Samson R. Coronary sinus lactate measurements in assessment of myocardial ischemia. Comparison with changes in lactate-pyruvate and beta-hydroxybutyrate-acetoacetate ratios and with release of hydrogen, phosphate and potassium ions from the heart. Am J Cardiol. 1973 Sep 7;32(3):295–305. doi: 10.1016/s0002-9149(73)80137-7. [DOI] [PubMed] [Google Scholar]
  12. Pantridge J. F., Adgey A. A. Pre-hospital coronary care. The mobile coronary care unit. Am J Cardiol. 1969 Nov;24(5):666–673. doi: 10.1016/0002-9149(69)90454-8. [DOI] [PubMed] [Google Scholar]
  13. Regan T. J., Harman M. A., Lehan P. H., Burke W. M., Oldewurtel H. A. Ventricular arrhythmias and K+ transfer during myocardial ischemia and intervention with procaine amide, insulin, or glucose solution. J Clin Invest. 1967 Oct;46(10):1657–1668. doi: 10.1172/JCI105657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Samet P. Hemodynamic sequelae of cardiac arrhythmias. Circulation. 1973 Feb;47(2):399–407. doi: 10.1161/01.cir.47.2.399. [DOI] [PubMed] [Google Scholar]
  15. Thomas M., Shulman G., Opie L. Arteriovenous potassium changes and ventricular arrhythmias after coronary artery occlusion. Cardiovasc Res. 1970 Jul;4(3):327–333. doi: 10.1093/cvr/4.3.327. [DOI] [PubMed] [Google Scholar]
  16. WEXLER J., PATT H. H. Evidence that serum potassium is not the etiological agent in ventricular fibrillation following coronary artery occlusion. Am Heart J. 1960 Oct;60:618–623. doi: 10.1016/0002-8703(60)90439-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES